Skip to main content

Table 5 Postoperative characteristics and clinical outcomes

From: Cardioprotective effect of remote ischemic preconditioning with postconditioning on donor hearts in patients undergoing heart transplantation: a single-center, double-blind, randomized controlled trial

Variables

RIPC+RIPostC (n = 60)

Control (n = 60)

P value

Length of ICU stay (d)

3.9(3, 5.8)

4(3, 6)

0.63

 ICU stay >7d

10(16.7%)

8(13.3%)

0.61

 ICU stay >14d

6(10%)

4(6.7%)

0.51

Mechanical ventilation time (h)

35(22, 44.5)

28.5(22, 41.8)

0.39

 Mechanical ventilation time > 48 h

12(20%)

11(18.3%)

0.75

 Mechanical ventilation time > 72 h

9(15%)

4(6.7%)

0.13

Postoperative hospital stay (d)

16(13, 22.5)

15(12.3, 22.8)

0.81

 Postoperative hospital stay >28d

11(18.3%)

6(10%)

0.19

In-hospital death

2(3.3%)

0

0.50

New onset stroke

1(1.7%)

0

1

Renal failure requiring dialysis

2(3.3%)

1(1.7%)

1

IABP support

4(6.7%)

6(10%)

0.51

ECMO support

3(5%)

2(3.3%)

1

Atrial fibrillation

3(5%)

0

0.24

Use of a temporary pacemaker

4(6.7%)

0

0.12

Arrhythmia requiring treatment

4(6.7%)

1(1.7%)

0.36

Re-operation

3(5%)

3(5%)

1

Re-intubation

1(1.7%)

1(1.7%)

1

Tracheotomy

1(1.7%)

1(1.7%)

1

Pulmonary infection

14(23.3%)

24(40%)

0.05

Deep sternal infection

3(5%)

0

0.24

Gastrointestinal bleeding

3(5%)

0

0.24

  1. Data are median (quartiles) or number (%)
  2. ICU, intensive care unit; IABP, intra-aortic balloon pump; ECMO, extracorporeal membrane oxygenation; RIPC, remote ischemic preconditioning; RIPostC, remote ischemic postconditioning